Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

Clinical trial NCT05512754 · RECRUITING

Trial details

NCT number: NCT05512754
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Elevated Serum PSA

Start date: 2022-08-01
Primary completion: 2027-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.